Fourth-line and Beyond Therapy in Advanced Non-small Cell Lung Cancer: 
A Retrospective Analysis

Fourth-line and Beyond Therapy in Advanced Non-small Cell Lung Cancer: 
A Retrospective Analysis

Background and objective A common consensus has been reached regarding first- and second-line therapies for advanced non-small cell lung cancer (NSCLC). The newest guideline from National Comprehensive Cancer Network (NCCN) also provides recommendations for third-line therapy. This study focused on...

Full description

Bibliographic Details
Main Authors: Xianfeng WANG, Meijuan HUANG, Li REN, Yong XU, Lu LI, Mei HOU, Jin WANG, Feng PENG, Jiang ZHU, Yongsheng WANG, You LU
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2014-12-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Fourth-line therapy
Survival and prognostic factors
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.03

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2014.12.03

Similar Items